This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Amyloid Solution Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Youngsoo Kim - Innovator in Pharmaceutical Composition
Introduction
Youngsoo Kim is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of degenerative brain diseases. His innovative approach has led to the development of a unique pharmaceutical composition that utilizes glycine transporter as an active ingredient.
Latest Patents
Youngsoo Kim holds a patent for a "Pharmaceutical Composition for Treating Degenerative Brain Disease, Including Glycine Transporter as Active Ingredient." This patent highlights his commitment to advancing medical science and improving treatment options for patients suffering from neurological disorders. He has 1 patent to his name, showcasing his innovative contributions to the field.
Career Highlights
Currently, Youngsoo Kim is associated with Amyloid Solution Inc., where he continues to work on groundbreaking research and development in pharmaceuticals. His role at the company allows him to collaborate with other talented professionals in the industry, further enhancing his impact on medical advancements.
Collaborations
Youngsoo Kim has worked alongside colleagues such as Seong Muk Kim and Seongjeong Park. Their collaborative efforts contribute to the innovative environment at Amyloid Solution Inc., fostering the development of new treatments and solutions in the pharmaceutical sector.
Conclusion
In summary, Youngsoo Kim is a dedicated inventor whose work in pharmaceutical compositions is paving the way for new treatments for degenerative brain diseases. His contributions are vital to the ongoing advancements in medical science, and his innovative spirit continues to inspire others in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile